Home › NDC Lookup › RxCUI directory › RxCUI 197988

Mitotane 500 MG Oral Tablet — RxCUI 197988

RxNorm drug concept · Semantic clinical drug
RxCUI 197988 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197988
Official nameMitotane 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)70 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mitotane: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lysodren is a targeted cancer drug used to treat adrenocortical carcinoma, which is a rare cancer of the adrenal gland. It is sometimes grouped with chemotherapy, but it works diff...
  • What exactly is Lysodren treating — is it chemotherapy?
  • Yes, it matters. Lysodren is a fat-loving drug, and eating — especially a high-fat meal — significantly helps your body absorb it. You should take it with food every time, and try...
  • Why do I need to take it with food, and does it matter what I eat?
📖 Read our full Mitotane guide →

🕸️ Concept Web — How Mitotane 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mitotane 500 MG Oral Tablet RxCUI 197988

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mitotane 7004
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lysodren 204257
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mitotane Oral Tablet 372942
    • Mitotane Oral Product 1165373
    • Mitotane Pill 1165374
    • Mitotane Oral Tablet [Lysodren] 368750
    • Lysodren Oral Product 1182084
    • Lysodren Pill 1182085
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mitotane 500 MG SCDC · 316312
  • Mitotane Oral Tablet SCDF · 372942
  • Mitotane Oral Product SCDG · 1165373
  • Mitotane Pill SCDG · 1165374

Brand-Name Concepts

  • Mitotane 500 MG Oral Tablet [Lysodren] SBD · 207373
  • Mitotane 500 MG [Lysodren] SBDC · 568141
  • Mitotane Oral Tablet [Lysodren] SBDF · 368750
  • Lysodren Oral Product SBDG · 1182084
  • Lysodren Pill SBDG · 1182085
  • Lysodren BN · 204257

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 197988 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68118-0080-60 1 BOTTLE in 1 CARTON (68118-080-60) / 100 TABLET in 1 BOTTL... Lysodren ESTEVE PHARMACEUTICALS, S.A. 1978-10-15
76336-0080-60 1 BOTTLE in 1 CARTON (76336-080-60) / 100 TABLET in 1 BOTTL... Lysodren HRA Pharma Rare Diseases 1978-10-15
Observed labelers: ESTEVE PHARMACEUTICALS, S.A. (1) · HRA Pharma Rare Diseases (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.